Applied DNA Sciences (APDN) announced that chairperson and CEO James Hayward is retiring from the company and will step down from the board of directors effective June 18, following a distinguished 20-year term. Furthermore, the board of Applied DNA has appointed Judy Murrah to the roles of chairperson, board director, and CEO in addition to retaining her current position as president. Murrah will lead the executive management team, which comprises Clay Shorrock, chief legal officer and president of LineaRx, the company’s biotherapeutics subsidiary, and Beth Jantzen, CFO.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APDN: